Interview with Joseph Lam , Managing Director, Beacons Pharmaceuticals
As one of the few surviving Singaporean manufactures, what has been the key to success? Our history spans more than 40 years and our success lies in our ability to…
Address: 2 Second Chin Bee Road Singapore 618769,Singapore
Tel: +65 6265 2336
Web: http://www.beacons.com.sg/
Beacons is Singapore’s largest manufacturer of generic pharmaceuticals, with a track record of success spanning of almost 40 years. The company is one of the leading providers of high quality, fully integrated contract pharmaceutical manufacturing services, it also produces over 200 therapeutics in a variety of dosage forms, sold under the Beacons brand name.
Beacons Pharmaceuticals owns and operates two PIC/S GMP certified manufacturing facilities in Singapore, a pharmacy operation in Malaysia, a JV in Sichuan, China, and owns Beacons Technology Systems, the developer of the innovative SPAH production space technology solution and Beacons SPAH solution.
Gernic drugs and SPAH system
As one of the few surviving Singaporean manufactures, what has been the key to success? Our history spans more than 40 years and our success lies in our ability to…
With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities…
As the world’s best airport, Changi Airport is also a fast growing hub for pharma freight shipping, and has demonstrated significant leadership in the world of pharma logistics hubs while…
What role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen…
In an exclusive interview with Brent Scott, President of Asia for Stryker, he highlights the growth potential of the region, Stryker’s aggressive acquisition strategy, and the strategic partnerships in the…
In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of…
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the…
In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic, topline-focused services in order to support Pharma companies…
Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the…
Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes within the family-owned business as “evolutionary” in nature, while highlighting…
Philips general manager of Health Systems, South East Asia, Johan Vooren highlights the company’s renewed commitment to Singapore with the recent opening of their APAC Center, while detailing the qualities…
Takeda’s President of Emerging Markets Business Unit, Giles Platford, speaks about his assignments across various global markets, his leadership philosophy, as well as the impressive international growth of the company.…
See our Cookie Privacy Policy Here